The global market for Pet Antibiotic is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Pet Antibiotic market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Pet Antibiotic market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Pet Antibiotic market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Pet Antibiotic market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Pet Antibiotic players cover Elanco, Zoetis, Merck Animal Health, Merial and Bayer HealthCare, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Pet Antibiotic market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Pet Antibiotic market, with both quantitative and qualitative data, to help readers understand how the Pet Antibiotic market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Pet Antibiotic market and forecasts the market size by Type (Oral, Injection and Others), by Application (Dogs, Cats and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Oral
Injection
Others
Segmentation by application
Dogs
Cats
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Elanco
Zoetis
Merck Animal Health
Merial
Bayer HealthCare
Boehringer Ingelheim GmbH
Ceva Sant? Animale
Virbac Group
HealthforAnimals
Cymedica
Dechra
Jinhe Biotechnology
Orion Corporation
Phibro Animal Health Corporation
Vetoquinol
Virbac
Zydus
Chapter Introduction
Chapter 1: Scope of Pet Antibiotic, Research Methodology, etc.
Chapter 2: Executive Summary, global Pet Antibiotic market size (sales and revenue) and CAGR, Pet Antibiotic market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Pet Antibiotic sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Pet Antibiotic sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Pet Antibiotic market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Elanco, Zoetis, Merck Animal Health, Merial, Bayer HealthCare, Boehringer Ingelheim GmbH, Ceva Sant? Animale, Virbac Group and HealthforAnimals, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pet Antibiotic Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Pet Antibiotic by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Pet Antibiotic by Country/Region, 2017, 2022 & 2028
2.2 Pet Antibiotic Segment by Type
2.2.1 Oral
2.2.2 Injection
2.2.3 Others
2.3 Pet Antibiotic Sales by Type
2.3.1 Global Pet Antibiotic Sales Market Share by Type (2017-2022)
2.3.2 Global Pet Antibiotic Revenue and Market Share by Type (2017-2022)
2.3.3 Global Pet Antibiotic Sale Price by Type (2017-2022)
2.4 Pet Antibiotic Segment by Application
2.4.1 Dogs
2.4.2 Cats
2.4.3 Others
2.5 Pet Antibiotic Sales by Application
2.5.1 Global Pet Antibiotic Sale Market Share by Application (2017-2022)
2.5.2 Global Pet Antibiotic Revenue and Market Share by Application (2017-2022)
2.5.3 Global Pet Antibiotic Sale Price by Application (2017-2022)
3 Global Pet Antibiotic by Company
3.1 Global Pet Antibiotic Breakdown Data by Company
3.1.1 Global Pet Antibiotic Annual Sales by Company (2020-2022)
3.1.2 Global Pet Antibiotic Sales Market Share by Company (2020-2022)
3.2 Global Pet Antibiotic Annual Revenue by Company (2020-2022)
3.2.1 Global Pet Antibiotic Revenue by Company (2020-2022)
3.2.2 Global Pet Antibiotic Revenue Market Share by Company (2020-2022)
3.3 Global Pet Antibiotic Sale Price by Company
3.4 Key Manufacturers Pet Antibiotic Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pet Antibiotic Product Location Distribution
3.4.2 Players Pet Antibiotic Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Pet Antibiotic by Geographic Region
4.1 World Historic Pet Antibiotic Market Size by Geographic Region (2017-2022)
4.1.1 Global Pet Antibiotic Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Pet Antibiotic Annual Revenue by Geographic Region
4.2 World Historic Pet Antibiotic Market Size by Country/Region (2017-2022)
4.2.1 Global Pet Antibiotic Annual Sales by Country/Region (2017-2022)
4.2.2 Global Pet Antibiotic Annual Revenue by Country/Region
4.3 Americas Pet Antibiotic Sales Growth
4.4 APAC Pet Antibiotic Sales Growth
4.5 Europe Pet Antibiotic Sales Growth
4.6 Middle East & Africa Pet Antibiotic Sales Growth
5 Americas
5.1 Americas Pet Antibiotic Sales by Country
5.1.1 Americas Pet Antibiotic Sales by Country (2017-2022)
5.1.2 Americas Pet Antibiotic Revenue by Country (2017-2022)
5.2 Americas Pet Antibiotic Sales by Type
5.3 Americas Pet Antibiotic Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pet Antibiotic Sales by Region
6.1.1 APAC Pet Antibiotic Sales by Region (2017-2022)
6.1.2 APAC Pet Antibiotic Revenue by Region (2017-2022)
6.2 APAC Pet Antibiotic Sales by Type
6.3 APAC Pet Antibiotic Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pet Antibiotic by Country
7.1.1 Europe Pet Antibiotic Sales by Country (2017-2022)
7.1.2 Europe Pet Antibiotic Revenue by Country (2017-2022)
7.2 Europe Pet Antibiotic Sales by Type
7.3 Europe Pet Antibiotic Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pet Antibiotic by Country
8.1.1 Middle East & Africa Pet Antibiotic Sales by Country (2017-2022)
8.1.2 Middle East & Africa Pet Antibiotic Revenue by Country (2017-2022)
8.2 Middle East & Africa Pet Antibiotic Sales by Type
8.3 Middle East & Africa Pet Antibiotic Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pet Antibiotic
10.3 Manufacturing Process Analysis of Pet Antibiotic
10.4 Industry Chain Structure of Pet Antibiotic
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pet Antibiotic Distributors
11.3 Pet Antibiotic Customer
12 World Forecast Review for Pet Antibiotic by Geographic Region
12.1 Global Pet Antibiotic Market Size Forecast by Region
12.1.1 Global Pet Antibiotic Forecast by Region (2023-2028)
12.1.2 Global Pet Antibiotic Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pet Antibiotic Forecast by Type
12.7 Global Pet Antibiotic Forecast by Application
13 Key Players Analysis
13.1 Elanco
13.1.1 Elanco Company Information
13.1.2 Elanco Pet Antibiotic Product Offered
13.1.3 Elanco Pet Antibiotic Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Elanco Main Business Overview
13.1.5 Elanco Latest Developments
13.2 Zoetis
13.2.1 Zoetis Company Information
13.2.2 Zoetis Pet Antibiotic Product Offered
13.2.3 Zoetis Pet Antibiotic Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Zoetis Main Business Overview
13.2.5 Zoetis Latest Developments
13.3 Merck Animal Health
13.3.1 Merck Animal Health Company Information
13.3.2 Merck Animal Health Pet Antibiotic Product Offered
13.3.3 Merck Animal Health Pet Antibiotic Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Merck Animal Health Main Business Overview
13.3.5 Merck Animal Health Latest Developments
13.4 Merial
13.4.1 Merial Company Information
13.4.2 Merial Pet Antibiotic Product Offered
13.4.3 Merial Pet Antibiotic Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Merial Main Business Overview
13.4.5 Merial Latest Developments
13.5 Bayer HealthCare
13.5.1 Bayer HealthCare Company Information
13.5.2 Bayer HealthCare Pet Antibiotic Product Offered
13.5.3 Bayer HealthCare Pet Antibiotic Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Bayer HealthCare Main Business Overview
13.5.5 Bayer HealthCare Latest Developments
13.6 Boehringer Ingelheim GmbH
13.6.1 Boehringer Ingelheim GmbH Company Information
13.6.2 Boehringer Ingelheim GmbH Pet Antibiotic Product Offered
13.6.3 Boehringer Ingelheim GmbH Pet Antibiotic Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Boehringer Ingelheim GmbH Main Business Overview
13.6.5 Boehringer Ingelheim GmbH Latest Developments
13.7 Ceva Sant
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)